-
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18. -
Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening.
Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:443-8. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.
Bindra R, Heath V, Nicolaides KH.
Clin Obstet Gynecol 2002;45:661-70. -
First trimester maternal serum placenta growth factor (PlGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18.
Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH.
Prenat Diagn 2001;21:718-22. -
Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
Paul C, Krampl E, Skentou C, Jurkovic D, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:481-4. -
Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH.
Am J Obstet Gynecol 2001;184:497-502. -
Repeatability of measurement of uterine artery pulsatility index using transvaginal color Doppler.
Papageorghiou AT, To MS, Yu CK, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:456-9. -
Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:441-9. -
First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH.
Obstet Gynecol 2001;98:608-11. -
Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation.
Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:583-6. -
Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks.
Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH.
Obstet Gynecol 2001;98:369-73. -
Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses.
Bindra R, Curcio P, Cicero S, Martin A, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:587-9. -
Distribution of fetal and embryonic hemoglobins in fetal erythroblasts enriched from maternal blood.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Haematol 2001;86:357-62. -
Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in fetal anemia.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Haematol 2001;86:1270-6. -
The influence of parity and gravidity on first trimester markers of chromosomal abnormality.
Spencer K, Ong CYT, Liao AWJ, Papademetriou D, Nicolaides KH.
Prenat Diagn 2000;20:792-4. -
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Spencer K, Heath V, Flack N, Ong C, Nicolaides KH.
Prenat Diagn 2000;20:635-9. -
The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities.
Spencer K, Ong CY, Liao AW, Nicolaides KH.
Prenat Diagn 2000;20:491-4. -
Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester.
Spencer K, Tul N, Nicolaides KH.
Prenat Diagn 2000;20:390-4. -
One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester.
Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH.
BJOG 2000;107:1271-5.